Press Releases
TAFALGIE THERAPEUTICS honoured with the CNRS Innovation Award presented to its co-founder and Scientific Director, Aziz Moqrich
TAFALGIE THERAPEUTICS honoured with the CNRS Innovation Award presented to its co-founder and Scientific Director, Aziz Moqrich Dr Aziz Moqrich ... Show more
TAFALGIE THERAPEUTICS Announces First Dose Escalation Data From TAFAFIRST, a Phase 1 Clinical Trial Evaluating TT5, a first-in-class Non-Opioid Treatment For Pain
TAFALGIE THERAPEUTICS Announces First Dose Escalation Data From TAFAFIRST, a Phase 1 Clinical Trial Evaluating TT5, a first-in-class Non-Opioid Treatment ... Show more
First Press Release
Tafalgie Therapeutics to benefit from the EIC Accelerator Program We are proud to announce that Tafalgie Therapeutics is one of ... Show more